Medicues Health News

Carboxymethyl-lysine: New blood test can predict increase risk of dying

by medicues

Carboxymethyl-lysine is a waste product of normal human metabolism.  It is formed from the oxidation of both carbohydrates (sugars) and fats.  This process is referred to as oxidative stress.

· Scientist have shown that older adults with high blood levels of Carboxymethyl-lysine (CML) are at higher risk of mortality, not only from heart disease and stroke but also all-cause mortality.  This was reported in the latest issue of the Journal of The American Geriatric Society.

· Scientists studied Carboxymethyl-lysine (CML) blood levels in over 1,000 adults over six years.  Over that period of time, 227 participants died.  The adults with the highest levels of Carboxymethyl-lysine (CML) had a 84% higher risk of all-cause mortality.  The adults with the highest levels of Carboxymethyl-lysine had over twice the risk of dying from heart disease or stroke compared with adults with the lowest levels of Carboxymethyl-lysine.

· Elevated levels of Carboxymethyl-lysine are a sign of oxidative stress.  Oxidative stress is associated with arterial plaque formation (plaque within arteries).  High levels of Carboxymethyl-lysine would be analogous to having high levels of cholesterol,  leading to obstructed arteries, heart attacks and strokes.

· The link between elevated levels of Carboxymethyl-lysine and risk of all-cause death is not completely clear.  The researchers in this study do not define the other causes of death of the adults in their study, so it is difficult to analyze the risk of dying from other causes besides vascular disease.

· Currently, we use information such as cholesterol levels, blood glucose levels and blood pressure to assess the risk of a patient’s mortality.  This new study gives us valuable insight into an additional risk factor and I suspect that we will use this type of test in the future to help optimally treat our adult patients.

Cristopher Geiler, MD
J Am Geriatr Soc 2009;57:1874-1880



Registered Medicues Contributors may comment on this article. Contributors, click here to log in.

If you have a comment for Medicues, please click here to send us a message through our contact form.
Medicues Perspectives

Watch here for comments on this article from our surgeons and experts!

Comments from Our Experts
Advertisement
Recent Stories

No heart benefit seen with fibrates in diabetics

ATLANTA (Reuters) - Adding a triglyceride lowering drug to cholesterol fighting statins provided no additional protection from heart attack, stroke... [via Reuters]

Abbott's heart valve device proves safe, effective

ATLANTA (Reuters) - An experimental, minimally invasive technique to repair the most common type of heart valve problem proved to be far safer and... [via Reuters]

Novartis drugs fail to help high-risk patients

ATLANTA (Reuters) - The Novartis diabetes drug Starlix failed to reduce progression to the disease or cut down on serious heart problems in patients... [via Reuters]

U.S. court rules again against vaccine-autism claims

WASHINGTON (Reuters) - Vaccines that contain a mercury-based preservative called thimerosal cannot cause autism on their own, a special U.S. court... [via Reuters]

Women on the pill live longer: study

LONDON (Reuters) - One of the world's largest studies of the contraceptive pill has found that women who have taken it can expect longer lives and... [via Reuters]